Domain
Laboratory
Lab results, specimens, LOINC codes and pathology
901 laboratory terms
The patient's respiratory rate recorded in association with a hematology encounter, relevant in conditions where blood oxygen-carrying capacity is compromised. Used in clinical documentation systems to correlate vital signs with findings from CBC results in cases of severe anemia or hematologic malignancy.
The quantitative or qualitative outcome value returned from a hematology laboratory test, such as hemoglobin level, platelet count, or white blood cell differential. Used in laboratory and clinical systems to support diagnosis, treatment monitoring, and trending of blood disorder management over time.
The structured review of organ systems documented during a hematology clinical encounter, capturing patient-reported symptoms relevant to blood disorders such as fatigue, bruising, or bleeding. Used in EHR systems to support evaluation and management coding for hematology visits.
The version or iteration number tracking updates made to a hematology order, result interpretation, or clinical document. Used in laboratory and EHR audit systems to maintain a change history for amended blood study reports, corrected values, or updated diagnostic interpretations.
A stratified risk level assigned to a patient based on hematology findings, such as bleeding risk from thrombocytopenia or infection risk from neutropenia. Used in clinical decision support and care management systems to trigger alerts, isolation protocols, or transfusion threshold interventions.
The administration pathway used to deliver a hematology-related treatment or therapeutic agent, such as intravenous for blood transfusions or subcutaneous for erythropoiesis-stimulating agents. Used in medication administration and infusion center records to document delivery method and support clinical protocols.
A composite numeric score derived from hematology test results or clinical indicators to stratify disease severity or treatment response, such as the International Prognostic Scoring System for myelodysplastic syndromes. Used in oncology and hematology systems to guide treatment decisions and monitor outcomes.
A numeric ordering value that defines the position of a hematology test, result component, or procedure within a series of related records. Used in laboratory information systems to organize multi-panel blood study components, serial monitoring draws, or ordered test batteries by their intended processing sequence.
The date on which a hematology service, laboratory test, or clinical procedure was performed or delivered to the patient. Used in claims processing, laboratory billing, and clinical documentation systems to establish the timeline of blood disorder care and support accurate date-of-service reporting.
A classification of the seriousness or clinical urgency of a hematologic finding or condition, such as mild, moderate, or severe anemia based on hemoglobin thresholds. Used in clinical triage systems, care management platforms, and reporting tools to prioritize interventions and track disease burden over time.
The biological sex of the patient associated with a hematology study or blood panel result. Used to apply sex-specific reference ranges for CBC components such as hemoglobin, hematocrit, and red blood cell counts, where normal values differ between male and female patients.
Identifies the originating system, facility, or specimen collection point from which hematology laboratory data was received. Used in clinical data integration to trace blood study results back to the submitting laboratory, hospital department, or external reference lab for audit and reconciliation purposes.
The calendar date on which a hematology study, blood panel order, or related treatment protocol was initiated. Used in clinical tracking to establish the timeline of a patient's hematologic evaluation, monitor ongoing conditions such as anemia or clotting disorders, and support longitudinal analysis.
The time of day at which a hematology study or blood specimen collection was initiated. Used in clinical workflows to sequence laboratory events, calculate turnaround times from collection to result, and ensure accurate timestamping of blood panel data within the patient's clinical record.
The U.S. state or Canadian province associated with the facility or laboratory where a hematology study was conducted or ordered. Used in geographic reporting, regulatory compliance tracking, and analysis of laboratory service distribution across regional health networks.
Indicates the current processing or result state of a hematology study, such as ordered, in-progress, resulted, corrected, or cancelled. Used in laboratory information systems to track workflow progression of blood panels and alert clinicians when results are finalized or require follow-up action.
The physical street address of the facility, clinic, or laboratory where a hematology study was ordered or performed. Used in laboratory data management to associate blood study records with specific collection or testing sites for reporting, billing, and network analysis purposes.
The concentration or dosage strength of a medication or therapeutic agent administered in conjunction with a hematology study, such as iron supplements, erythropoietin, or chemotherapy drugs. Used to correlate treatment dosage with resulting blood panel values during hematologic condition management.
A partial aggregate value derived from a subset of hematology study results or associated charges, such as a subtotal of specific blood panel components or laboratory fees. Used in clinical reporting and billing workflows to break down composite hematology encounter data into meaningful grouped summaries.
A system-generated unique identifier assigned to a hematology study record within a laboratory information system or clinical data warehouse. Used to uniquely reference and link blood panel orders, results, and related clinical events across disparate healthcare systems and data integration pipelines.